SCHEMBL575708

SCHEMBL575708

O=S1(=O)CS(=O)(=O)OCCCO1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL575916 0.93
SCHEMBL10418183 0.90
SCHEMBL706795 0.83
SCHEMBL29186050 0.76
SCHEMBL23700086 0.76
SCHEMBL26967 0.73
SCHEMBL23700075 0.73
SCHEMBL23700061 0.73
SCHEMBL46068 0.73
SCHEMBL10417126 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712192-A1 ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY CONTAINING SAME Central Glass Co., Ltd. (JP) 2026-03-18 EP claimed
US-20250105353-A1 Electrolyte Solution for Nonaqueous Electrolyte Batteries, and Nonaqueous Electrolyte Battery Using Same CENTRAL GLASS COOMPANY, LIMITED (JP) 2025-03-27 US claimed
US-12199241-B2 Electrolyte solution for nonaqueous electrolyte batteries, and nonaqueous electrolyte battery using same CENTRAL GLASS COMPANY, LIMITED (JP) 2025-01-14 US claimed
CN-114039093-A Electrolyte additive, electrolyte, lithium ion battery and application of electrolyte additive and electrolyte 上海电气国轩新能源科技有限公司 2022-02-11 CN claimed
CN-107004903-B Electrolyte for nonaqueous electrolyte battery and lithium nonaqueous electrolyte battery 中央硝子株式会社 2020-11-06 CN claimed
EP-4016686-B1 NONAQUEOUS ELECTROLYTE SOLUTION, NONAQUEOUS ELECTROLYTE BATTERY AND COMPOUND CENTRAL GLASS CO LTD (JP) 2026-05-20 EP disclosed
EP-4738518-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME Central Glass Company, Limited (JP) 2026-05-06 EP disclosed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
EP-4718567-A1 NONAQUEOUS SOLVENT SOLUTION AND METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION Central Glass Company, Limited (JP) 2026-04-01 EP disclosed
EP-4290638-B1 NONAQUEOUS ELECTROLYTIC SOLUTION, NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY, AND COMPOUND CENTRAL GLASS CO LTD (JP) 2026-03-25 EP disclosed
EP-4712192-A1 ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY CONTAINING SAME Central Glass Co., Ltd. (JP) 2026-03-18 EP disclosed
US-12494507-B2 Flame retardants for battery electrolytes ALBEMARLE CORPORATION (US) 2025-12-09 US disclosed
US-20100062332-A1 LITHIUM ION SECONDARY BATTERY NEC TOKIN CORPORATION (JP) 2010-03-11 US disclosed
EP-2144321-A1 NONAQUEOUS ELECTROLYTE FOR RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE Mitsubishi Chemical Corporation (JP) 2010-01-13 EP disclosed
US-20070212613-A1 Polymer gel electrolyte and polymer secondary battery using the same NEC TOKIN CORPORATION (JP) 2007-09-13 US disclosed
US-4950768-A ANTICARCINOGENIC AGENTS CRONYN MARSHALL W (US) 1990-08-21 US disclosed
EP-0168478-B1 CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES CRONYN, Marshall W. (US) 1989-04-05 EP disclosed
EP-0168478-A4 CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES. CRONYN MARSHALL W 1986-11-07 EP disclosed
EP-0168478-A1 CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES. CRONYN MARSHALL W 1986-01-22 EP disclosed
WO-1985003075-A1 CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES CRONYN MARSHALL W 1985-07-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same ASH2L, OLA1, ODC1 TSHR 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.